Title of article :
Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial
Author/Authors :
Anne-Katrin Sjolie، نويسنده , , Ronald Klein، نويسنده , , Massimo Porta، نويسنده , , Trevor Orchard، نويسنده , , John Fuller، نويسنده , , Hans-Henrik Parving، نويسنده , , Rudy Bilous، نويسنده , , Nish Chaturvedi، نويسنده ,
Issue Information :
روزنامه با شماره پیاپی سال 2008
Pages :
9
From page :
1385
To page :
1393
Abstract :
Summary Background Diabetic retinopathy remains a leading cause of visual loss in people of working age. We examined whether candesartan treatment could slow the progression and, secondly, induce regression of retinopathy in people with type 2 diabetes. M
Journal title :
The Lancet
Serial Year :
2008
Journal title :
The Lancet
Record number :
593605
Link To Document :
بازگشت